Weight Loss
15
 min read

Check HbA1c at Home: UK Guide to Testing, Accuracy and Results

Written by
Bolt Pharmacy
Published on
16/3/2026

Checking your HbA1c at home has become an increasingly accessible option for people in the UK who want to monitor their blood sugar control or assess their risk of type 2 diabetes. HbA1c — glycated haemoglobin — reflects your average blood glucose over the preceding two to three months, making it a valuable marker for both diagnosis and ongoing management. Whether you have an existing diabetes diagnosis or simply want peace of mind, understanding how home testing works, what your result means, and when to seek professional advice is essential for using this tool safely and effectively.

Summary: You can check your HbA1c at home in the UK using a postal finger-prick blood test kit sent to a UKAS-accredited laboratory, though results should be confirmed by NHS venous blood testing for any clinical diagnosis.

  • HbA1c measures average blood glucose over two to three months by detecting glycated haemoglobin in red blood cells.
  • A reading of 48 mmol/mol (6.5%) or above indicates type 2 diabetes; 42–47 mmol/mol (6.0–6.4%) indicates non-diabetic hyperglycaemia (prediabetes).
  • Home postal kits use dried blood spot (DBS) technology; choose kits from UKAS-accredited, IFCC-aligned laboratories participating in UK NEQAS for reliable results.
  • Conditions such as haemoglobin variants, anaemia, and chronic kidney disease can affect HbA1c accuracy in both home and clinical settings.
  • Home testing cannot confirm a new diabetes diagnosis — NHS laboratory venous blood testing is required for formal clinical decisions.
  • Always discuss an unexpectedly high or rising home result with your GP or diabetes team rather than adjusting medication independently.

What Is HbA1c and Why Does It Matter?

HbA1c reflects average blood glucose over two to three months and is used to diagnose type 2 diabetes (≥48 mmol/mol) and monitor glycaemic control in people already living with diabetes.

HbA1c — formally known as glycated haemoglobin — is a blood marker that reflects your average blood glucose levels over the preceding two to three months. When glucose circulates in the bloodstream, it binds to haemoglobin (the protein inside red blood cells), forming glycated haemoglobin. Because red blood cells have a lifespan of around 120 days, the HbA1c measurement provides a reliable window into longer-term blood sugar control rather than a single snapshot in time. It is worth noting that the most recent four to six weeks of blood glucose levels have the greatest influence on the result.

In clinical practice, HbA1c is used for two key purposes:

  • Diagnosing type 2 diabetes and non-diabetic hyperglycaemia — an HbA1c of 48 mmol/mol (6.5%) or above is diagnostic of type 2 diabetes, whilst a reading between 42–47 mmol/mol (6.0–6.4%) indicates non-diabetic hyperglycaemia (sometimes called prediabetes)

  • Monitoring glycaemic control in people already living with diabetes, helping clinicians and patients assess whether treatment targets are being met

Importantly, HbA1c is not appropriate for diagnosing diabetes in the following situations, where alternative tests (such as fasting plasma glucose or an oral glucose tolerance test) should be used instead:

  • Suspected type 1 diabetes (where clinical presentation usually requires urgent assessment)

  • Children and young people

  • Pregnancy (including suspected gestational diabetes, which is diagnosed using an oral glucose tolerance test)

  • Within approximately two months of an acute illness or acute hyperglycaemia

  • Conditions affecting red blood cell turnover or haemoglobin structure, such as haemolytic anaemia, iron deficiency anaemia, haemoglobin variants (e.g., sickle cell trait, thalassaemia), recent blood transfusion, or chronic kidney disease

NICE guidelines (NG28 for type 2 diabetes and NG17 for type 1 diabetes) recommend regular HbA1c monitoring for people with diabetes, typically every three to six months depending on stability of control. Poor glycaemic control over time is associated with serious long-term complications, including cardiovascular disease, diabetic retinopathy, nephropathy, and peripheral neuropathy. Understanding your HbA1c result is therefore a cornerstone of effective diabetes self-management and prevention.

GLP-1 / GIP

Mounjaro®

Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.

  • ~22.5% average body weight loss
  • Significant weight reduction
  • Improves blood sugar levels
  • Clinically proven weight loss
GLP-1

Wegovy®

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.

  • ~16.9% average body weight loss
  • Boosts metabolic & cardiovascular health
  • Proven, long-established safety profile
  • Weekly injection, easy to use

Can You Check Your HbA1c at Home in the UK?

Yes, home HbA1c testing is available in the UK via postal finger-prick kits, but results should not replace NHS laboratory testing when a formal clinical diagnosis is required.

Yes — it is possible to check your HbA1c at home in the UK, and the availability of home testing options has grown considerably in recent years. The most widely available consumer option is a postal self-collection kit, which allows you to collect a small finger-prick blood sample at home and send it to an accredited laboratory by post. Some handheld point-of-care analysers also exist, but many of these are designed for use by trained healthcare professionals in clinical settings rather than for unsupervised self-testing.

When purchasing a home kit, look for one that carries a CE or UKCA mark specifically indicating it is intended for self-testing — CE marking remains recognised in Great Britain. This designation confirms the device has been assessed for safe use by members of the public without professional supervision.

Home HbA1c testing is particularly relevant for:

  • People with diagnosed diabetes who wish to monitor their control between NHS appointments

  • Individuals who are concerned about their risk of type 2 diabetes and want an early indication before seeing their GP

  • Those who find it difficult to attend a GP surgery or clinic due to work commitments, mobility issues, or anxiety

It is important to note that whilst home testing can be a useful and convenient tool, a result obtained at home should not replace formal NHS testing when a clinical decision needs to be made. For a new diagnosis of diabetes to be confirmed, NICE and NHS guidance recommend a laboratory-analysed venous blood sample using an IFCC-aligned, NGSP-traceable method — usually repeated on a second occasion unless symptoms are clearly present. Home testing is best viewed as a supplementary monitoring tool rather than a definitive diagnostic method.

How Home HbA1c Test Kits Work

Most home kits use a dried blood spot (DBS) method — you prick your finger, apply blood to a card, and post it to a UKAS-accredited laboratory, receiving results within a few days.

Home HbA1c test kits available to consumers in the UK are most commonly postal dried blood spot (DBS) kits. These require you to collect a small capillary blood sample via a finger-prick lancet, apply it to a specially treated card, and post it to a laboratory for analysis. Some handheld point-of-care devices are also marketed directly to consumers, though many such devices are primarily intended for trained operators in clinical settings; always check the product labelling to confirm it is approved for self-testing.

  1. Postal DBS kits typically involve the following steps:
  2. Pricking your finger with the lancet provided
  3. Applying drops of blood onto the treated sample card
  4. Allowing the card to dry fully in a clean, dry environment
  5. Posting it to the laboratory in the prepaid envelope provided
  6. Receiving your result — usually within a few days — via email, an online portal, or post

When selecting a postal kit, look for laboratories accredited by UKAS (United Kingdom Accreditation Service) to ISO 15189 (the international standard for medical laboratories). It is also advisable to check that the laboratory uses IFCC-aligned and NGSP-traceable methods and participates in an external quality assessment (EQA) scheme such as UK NEQAS for HbA1c. These measures help ensure that results are comparable to those produced by NHS laboratories.

Always follow the manufacturer's instructions carefully. Improper sample collection — such as insufficient blood volume, failure to dry the card fully, or exposure to high humidity or heat before posting — can affect result accuracy. Post the sample promptly after collection as directed.

Accuracy of Home Testing Compared to NHS Lab Results

Postal kits using UKAS-accredited, IFCC-aligned laboratories and EQA-participating methods can produce broadly comparable results to NHS labs, but no universal accuracy figure applies to all consumer products.

The accuracy of home HbA1c testing varies depending on the method and laboratory used. Postal kits that use UKAS-accredited laboratories employing IFCC-aligned, NGSP-traceable methods (such as high-performance liquid chromatography or immunoassay) and that participate in EQA schemes such as UK NEQAS can produce results that are broadly comparable to NHS laboratory standards. However, the degree of agreement with a venous laboratory sample will depend on the specific kit and laboratory; no single accuracy figure applies universally, and you should refer to the manufacturer's performance data for the product you are using.

NHS laboratories operate under ISO 15189 accreditation with rigorous internal quality controls and mandatory EQA participation, which provides a higher level of ongoing performance assurance than most consumer products.

Factors that can affect the accuracy of any HbA1c measurement — whether at home or in a clinical setting — include:

  • Haemoglobin variants (e.g., sickle cell trait, thalassaemia) — these can interfere with certain assay methods and produce falsely low or high readings; the effect is method-dependent, so check the manufacturer's information

  • Conditions affecting red blood cell turnover — including iron deficiency anaemia, haemolytic anaemia, chronic kidney disease, recent erythropoietin use, splenectomy, or recent blood transfusion — all of which can skew results

  • Improper sample collection — insufficient blood volume or contamination can reduce reliability

  • Pre-analytical factors specific to DBS samples — including exposure to high humidity or heat, prolonged transit time, or failure to dry the card adequately before posting

CE/UKCA-marked self-test IVDs (in vitro diagnostic devices) must meet defined safety and performance requirements under MHRA regulations; however, they are not routinely subject to the same ongoing EQA oversight as NHS laboratories. For this reason, a home result — particularly one that is unexpectedly high or low — should always be discussed with a healthcare professional and, where clinically indicated, confirmed with a venous blood sample analysed in a UKAS-accredited laboratory. Home results are best used as a trend-monitoring tool rather than a standalone diagnostic measure.

HbA1c Result mmol/mol % (NGSP/DCCT) Interpretation Recommended Action
Normal range Below 42 Below 6.0% Low risk of diabetes Maintain healthy lifestyle; retest if risk factors develop
Non-diabetic hyperglycaemia (prediabetes) 42–47 6.0–6.4% Elevated risk of type 2 diabetes See GP; consider referral to NHS Diabetes Prevention Programme (Healthier You)
Diagnostic threshold — type 2 diabetes 48 or above 6.5% or above Indicative of type 2 diabetes; requires laboratory confirmation See GP urgently; confirm with UKAS-accredited venous blood sample
NICE target — type 2 (lifestyle/non-hypoglycaemic drugs) 48 6.5% Optimal control target per NICE NG28 Discuss with diabetes team if consistently above target
NICE target — type 2 (sulphonylureas or insulin) 53 7.0% Higher target to reduce hypoglycaemia risk per NICE NG28 Review medication with diabetes team if above agreed target
NICE target — type 1 diabetes 48 6.5% Recommended target per NICE NG17 if achievable without problematic hypoglycaemia Specialist diabetes team review; individual targets may vary
Any result with acute symptoms Any Any Symptoms of DKA or HHS (vomiting, confusion, rapid breathing) are a medical emergency Call 999 or go to A&E immediately; do not rely on home HbA1c result

When to See Your GP or Diabetes Team About Your HbA1c

See your GP if your home result is 48 mmol/mol or above, or in the prediabetes range (42–47 mmol/mol); seek emergency care immediately if symptoms suggest diabetic ketoacidosis or HHS.

Whilst home HbA1c testing can provide reassurance and useful information, there are several circumstances in which you should contact your GP or diabetes care team — or seek urgent help — rather than relying solely on a home result.

Seek emergency help (call 999 or go to A&E) if you or someone else has symptoms that may suggest diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS), including:

  • Nausea, vomiting, or severe abdominal pain

  • Deep or rapid breathing

  • Drowsiness, confusion, or difficulty staying awake

  • Severe dehydration

  • Fruity or acetone-smelling breath (more typical of DKA)

These are medical emergencies and must not be managed at home based on an HbA1c reading.

Contact your GP if:

  • Your home result is 48 mmol/mol (6.5%) or above, as this may indicate diabetes and requires formal confirmation with a laboratory venous blood test

  • Your result is in the non-diabetic hyperglycaemia range (42–47 mmol/mol) and you have not previously been assessed — early intervention can significantly reduce the risk of progression to type 2 diabetes

  • You have symptoms of high blood glucose, such as increased thirst, frequent urination, unexplained weight loss, or fatigue, regardless of your home result

  • Your result has risen significantly compared to a previous reading, suggesting deteriorating glycaemic control

Contact your diabetes team if:

  • You are already on diabetes medication and your HbA1c is consistently above your agreed target

  • You are experiencing recurrent hypoglycaemia (low blood sugar episodes), which may indicate your treatment needs adjusting

  • You are pregnant or planning pregnancy — tighter glycaemic targets apply, specialist input is essential, and it is important to note that gestational diabetes is diagnosed using an oral glucose tolerance test (OGTT), not HbA1c

Never adjust your diabetes medication — including insulin doses — based solely on a home HbA1c result without first discussing it with your healthcare team. Home testing is a valuable adjunct to professional care, not a replacement for it.

Understanding Your HbA1c Result and Next Steps

UK results are reported in mmol/mol; a reading below 42 is normal, 42–47 indicates prediabetes requiring lifestyle intervention, and 48 or above requires laboratory confirmation of diabetes.

Once you have your HbA1c result, understanding what it means in context is essential. Results in the UK are reported in mmol/mol (the IFCC standard), though some older resources may still reference the percentage (NGSP/DCCT) format. The key reference ranges are:

  • Below 42 mmol/mol (6.0%) — Within the normal range; low risk of diabetes

  • 42–47 mmol/mol (6.0–6.4%) — Non-diabetic hyperglycaemia (prediabetes); lifestyle intervention recommended

  • 48 mmol/mol (6.5%) or above — Diagnostic threshold for type 2 diabetes (requires laboratory confirmation)

For people already living with type 2 diabetes, NICE (NG28) recommends an HbA1c target of 48 mmol/mol (6.5%) for those managed with lifestyle measures or non-hypoglycaemic medications, and 53 mmol/mol (7.0%) for those on medications that carry a risk of hypoglycaemia, such as sulphonylureas or insulin. For adults living with type 1 diabetes, NICE (NG17) recommends a target of 48 mmol/mol (6.5%) if this is achievable without problematic hypoglycaemia. Individual targets may vary based on age, comorbidities, and personal circumstances, and should always be agreed with your diabetes care team.

If your result falls in the non-diabetic hyperglycaemia range, the NHS Diabetes Prevention Programme (NHS DPP) — also known as Healthier You — offers a structured, evidence-based lifestyle intervention that has been shown in UK evaluations to reduce the risk of developing type 2 diabetes. Eligibility is typically based on a recent HbA1c in the non-diabetic hyperglycaemia range or a high score on a validated risk assessment tool. Your GP can refer you, or you may be able to self-refer depending on your local area; check the NHS England website for current eligibility and referral routes.

Regardless of your result, it is worth reviewing your lifestyle factors — including diet, physical activity, weight management, and smoking cessation — as these remain among the most powerful tools for improving long-term glycaemic health. Use your home result as a starting point for a conversation with your healthcare team, not as a cause for alarm or complacency.

Frequently Asked Questions

How accurate are home HbA1c test kits compared to NHS laboratory results?

Postal home kits using UKAS-accredited laboratories with IFCC-aligned methods and EQA participation can produce results broadly comparable to NHS labs. However, accuracy varies by product, and any unexpectedly high or low result should be confirmed with a venous blood sample at an NHS laboratory.

Can a home HbA1c test diagnose type 2 diabetes?

No — a home HbA1c result cannot formally diagnose type 2 diabetes. NICE and NHS guidance require a laboratory-analysed venous blood sample, usually repeated on a second occasion, before a diagnosis can be confirmed.

What should I do if my home HbA1c result is 48 mmol/mol or above?

Contact your GP as soon as possible, as a result of 48 mmol/mol (6.5%) or above may indicate type 2 diabetes and requires formal confirmation with an NHS venous blood test. Do not adjust any diabetes medication based solely on a home result.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Book a discovery call

and discuss your eligibility for the Fella Program

Book your free call